ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

New Chemotherapy, Other Modality Progress Described

March 30, 1979

Fox Chase Biochemist Automates DNA Production

July 20, 1990

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

Breast Implants Don’t Cause Tissue Disorders, NCI Finds

October 29, 2004